Investment company Stonepine Capital Management, LLC buys Recro Pharma, SciClone Pharmaceuticals, Novelion Therapeutics, Ophthotech, Enanta Pharmaceuticals, Veracyte, BioDelivery Sciences International, Sucampo Pharmaceuticals, Cardiome Pharma, Trinity Biotech PLC, sells Tobira Therapeutics, Cutera, Derma Sciences, Pacira Pharmaceuticals during the 3-months ended 2016-12-31, according to the most....More>>>
Shares of Goldman Sachs Group Inc. (NYSE:GS) plunged 5% in active trading on Tuesday after its earnings failed to meet Wall Street’s expectations.
Goldman reported earnings of $5.15 per share, below the consensus forecast of $5.31 per share. A noteworthy decline in Fixed Income, Currency, and Commodities (FICC) income stunned analysts,....More>>>
The short interest data have come out for the November 15 settlement date. It is important to note that semiconductor trends are considered to be leading indicators of technology and broader electronics demand. A strong rally in the tech sector largely pushed many of these companies to new highs, as the Dow and S&P have both hit new all-time highs.
The November 15 short interest data....More>>>
Although the S&P 500 closed slightly lower Thursday, the index is still near its all time high as investors continue to enjoy an 8-year bull market.
However, many equity analysts remain cautious as stocks appear to be trading at inflated multiples. Goldman Sachs even went on record saying that they believe the U.S. bull market is in its last few innings.
But what is an enterprising....More>>>
Michael E. Lewitt
By now, it should be apparent to anybody with a functioning cerebellum that our political and economic policy leaders are abject failures. After years of impotent monetary policy at the hands of the Fed, decades of incompetent foreign policy by several administrations, a dormant and corrupt Congress, and an activist Supreme Court rewriting the Constitution, the world....More>>>